Privatized Medicare Advantage for All: The Latest Assault on U.S. Health Care

Abstract

Privatized Medicare Advantage has grown rapidly among seniors in the United States in recent years. It is now being promoted actively by corporate stakeholders and even by the Centers for Medicare and Medicaid Services itself as a new proposal to extend this approach to cover all Americans. There is little public awareness, however, of the current costs and adverse impacts of Medicare Advantage on enrollees’ access, costs, and outcomes of care while deceptive marketing and disinformation prevails. This article traces the history of Medicare Advantage, outlines false assertions being made by proponents of Medicare Advantage for All, and refutes them based on evidence and their track record. If ever enacted, it would end up lining the pockets of corporate stakeholders and Wall Street investors while limiting access to care, increasing costs, and reducing quality and outcomes of care. The United States already ranks last for access, equity, and outcomes of care in periodic studies by the Commonwealth Fund. This proposal would worsen that situation while costing patients, families, and taxpayers more as their health suffers.